Cocrystal Pharma, Inc. (COCP) Financials

COCP Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 4.6 million 3.6 million
March 31, 2026 7.4 million 3.3 million
Dec. 31, 2025 9.7 million 3.4 million
Sept. 30, 2025 10.4 million 2.8 million

COCP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -2.5 million 92000
March 31, 2026 -2.3 million 84000
Dec. 31, 2025 -1.7 million 56000
Sept. 30, 2025 -1.6 million 48000

COCP Net Income

No data available :(

COCP Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 2.2 million - 1.3 million
March 31, 2026 4.7 million - 1.1 million
Dec. 31, 2025 7.0 million - 1.5 million
Sept. 30, 2025 7.7 million - 1.6 million

COCP Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 13.8 million
March 31, 2026 13.8 million
Dec. 31, 2025 11.3 million
Sept. 30, 2025 11.0 million

COCP Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 2.1 million 1.1 million -
March 31, 2026 - 1.4 million 1.2 million -
Dec. 31, 2025 - 1.6 million 862000 39000
Sept. 30, 2025 12561 954000 1.1 million -

COCP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 105000 -
March 31, 2026 225000 91000
Dec. 31, 2025 - -1.4 million
Sept. 30, 2025 - 954000

COCP Revenue by Segment
Graph available only for paid members. Upgrade to see it.

COCP

Price: $1.08

52 week price:
0.76
2.03

Earnings Per Share: -0.74 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 92200

Market Capitalization: 15.3 million

Links: